secwatch.observer — SEC 8-K summary
======================================

Issuer:     Unicycive Therapeutics, Inc. (UNCY)
CIK:        0001766140
Form:       8-K
Filed at:   2026-04-06T23:59:59+00:00
Accession:  0001213900-26-040179
Event type: leadership
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Director Gaurav Aggarwal resigns from Unicycive board effective April 6
-----------------------------------------------------------------------

- Gaurav Aggarwal resigned from the Board of Directors on April 6, 2026.
- Resignation was not due to any disagreement with the Company or management.
- Company expressed gratitude for Dr. Aggarwal's service on the Board.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1766140/000121390026040179/0001213900-26-040179-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1766140/000121390026040179/ea0285174-8k_unicycive.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-040179

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer